Cargando…

New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes

Type 1 diabetes mellitus results from the progressive and specific autoimmune destruction of insulin-secreting pancreatic B-cells, which develops over a period of years and continues after the initial clinical presentation. The ultimate goal of therapeutic intervention is prevention or reversal of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cernea, S, Pozzilli, P
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701557/ https://www.ncbi.nlm.nih.gov/pubmed/19046214 http://dx.doi.org/10.1111/j.1464-5491.2008.02556.x

Ejemplares similares

β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
por: Cernea, Simona, et al.
Publicado: (2009)

C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277: An Exploratory Study
por: Buzzetti, Raffaella, et al.
Publicado: (2011)

Proposal for generating new beta cells in a muted immune environment for type 1 diabetes
por: Levetan, Claresa, et al.
Publicado: (2013)

No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 Diabetes: The IMDIAB XIII trial
por: Bizzarri, Carla, et al.
Publicado: (2010)

Similarities and differences between multiple sclerosis and type 1 diabetes
por: Pozzilli, Valeria, et al.
Publicado: (2021)

Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function
por: Li, Xin, et al.
Publicado: (2020)

Diabetes and beta cell function: from mechanisms to evaluation and clinical implications
por: Cernea, Simona, et al.
Publicado: (2013)

Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
por: Pozzilli, Paolo, et al.
Publicado: (2018)

A new potential mode of cardiorenal protection of KLOTHO gene variability in type 1 diabetic adolescents
por: Słomiński, Bartosz, et al.
Publicado: (2020)

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes
por: Coomans de Brachène, Alexandra, et al.
Publicado: (2022)

The Soluble CTLA-4 Splice Variant Protects From Type 1 Diabetes and Potentiates Regulatory T-Cell Function
por: Gerold, Kay D., et al.
Publicado: (2011)

One size does not fit all glycemic targets for type 2 diabetes
por: Pozzilli, Paolo, et al.
Publicado: (2014)

Impaired exocrine pancreatic function in different stages of type 1 diabetes
por: Dozio, Nicoletta, et al.
Publicado: (2021)

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Orban, Tihamer, et al.
Publicado: (2009)

The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus
por: Leung, Po Sing
Publicado: (2016)

Neratinib protects pancreatic beta cells in diabetes
por: Ardestani, Amin, et al.
Publicado: (2019)

FRI593 Ergocalciferol And Pancreatic β-Cell Function In New-onset Type 1 Diabetes: A Randomized Controlled Trial
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2023)

Pancreatic Function, Type 2 Diabetes, and Metabolism in Aging
por: Gong, Zhenwei, et al.
Publicado: (2012)

Assessment of Type 1 Diabetes Risk Conferred by HLA-DRB1, INS-VNTR and PTPN22 Genes Using the Bayesian Network Approach
por: Portuesi, Rosalba, et al.
Publicado: (2013)

Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment
por: Mahoney, Alexandra L. G., et al.
Publicado: (2022)

Potential Protective Function of Adiponectin in Diabetic Retinopathy
por: Deng, Hui, et al.
Publicado: (2023)

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
por: Strollo, Rocky, et al.
Publicado: (2017)

Insulin protects against type 1 diabetes mellitus-induced ultrastructural abnormalities of pancreatic islet microcirculation
por: Wang, Bing, et al.
Publicado: (2020)

Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potential
por: Strachan, Erin, et al.
Publicado: (2023)

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2008)

New-onset Type 1 Diabetes Mellitus with Diabetic Ketoacidosis and Pancreatitis in a Patient with COVID-19
por: Alfishawy, Mostafa, et al.
Publicado: (2021)

New-Onset Type 1 Diabetes in a Child With Diabetic Ketoacidosis and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca J, et al.
Publicado: (2023)

Further Studies on Antioxidant Potential and Protection of Pancreatic β-Cells by Embelia ribes in Experimental Diabetes
por: Bhandari, Uma, et al.
Publicado: (2007)

Deletion of Pten in Pancreatic β-Cells Protects Against Deficient β-Cell Mass and Function in Mouse Models of Type 2 Diabetes
por: Wang, Linyuan, et al.
Publicado: (2010)

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
por: Singh, Kailash, et al.
Publicado: (2022)

Epigenetic aspects of pancreatic beta cell function in type 2 diabetes
por: Cnop, Miriam
Publicado: (2014)

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
por: Ahn, Chang Ho, et al.
Publicado: (2023)

Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells
por: Cojocaru, Florentina, et al.
Publicado: (2021)

Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
por: Napoli, Nicola, et al.
Publicado: (2013)

The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
por: Benninger, Richard K. P., et al.
Publicado: (2018)

Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes
por: Radlinger, Bernhard, et al.
Publicado: (2020)

Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9
por: Hernandez, Marta, et al.
Publicado: (2015)

Pancreatic beta cell autophagy is impaired in type 1 diabetes
por: Muralidharan, Charanya, et al.
Publicado: (2021)

HDL functionality in type 1 and type 2 diabetes: new insights
por: Chapman, M. John
Publicado: (2022)

Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes
por: Son, Jinsook, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13u9gssosm49ulvueuia50mpl4